QuickVue Influenza A+B Clinical Field Trial

N/ACompletedNCT00491283

Quidel Corporation

Overview

A comparative study of different swab types used for collection of specimens for rapid inluenza testing

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

SINGLE

Conditions

Influenza

Interventions

Swab Specimen Collection (QuickVue)DEVICE

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: Subjects must have: * Fever (\>38°C) (at time of visit or within the previous 48 hrs by history) and at least two of the following symptoms: * Chills/sweats * Cough * Dyspnea (labored, difficult breathing) * Fatigue * Headache * Myalgia (deep muscle aches) * Nasal congestion * Runny nose * Sore throat Exclusion Criteria: * Patients who are undergoing treatment with antivirals, now or within the last 7 days cannot be included in this study.

Locations (1)

Sydney Airport Medical Centre

Mascot, New South Wales, Australia

Outcomes

Primary Outcomes

Sensitivity and Specificity

Time frame: five months

Secondary Outcomes

Sensitivity and Specificity

Time frame: Positive and Negative Predictive Values

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.